EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Vocal Fold Scar Treatment via Controlled Dexamethasone Delivery With a Light‐Activatable Implant

Denzel Ryan D Cruz iD, Nour Awad iD, Avery Zheng iD, Alexander Karabachev iD, Charles Farbos de Luzan iD, Yoonjee C Park iD, Gregory R Dion iD

The Laryngoscope · 2026

DOI: 10.1002/lary.70149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, 2026. Verfasst von Denzel Ryan D Cruz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Scientist Training Program, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Dexamethasone, Vocal Cords, Cicatrix, Glucocorticoids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, NIDCD NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Intralesional steroid injections for vocal fold (VF) scarring are rapidly cleared, limiting their effectiveness. This study evaluates the efficacy of a light‐activatable dexamethasone implant compared to a single steroid injection for VF scar healing.

Methods

Ten rabbits underwent endoscopic VF injury and were treated with either a dexamethasone injection or a light‐activatable implant; injured‐only and no‐injury VFs served as controls. On days 0 and 21, VF implants were irradiated with a near‐infrared pulsed laser for 1 min. Larynges were harvested after 42 days. High‐speed video (> 10 kHz) of excised larynges captured VF vibrations for kymographic analysis. Normal force, structural stiffness, and displacement were measured. Data were analyzed with appropriate statistical tests.

Results

Compared to injury‐only VFs, implant‐treated VFs demonstrated significantly reduced normal force and stiffness (5.28 ± 0.77 mN vs. 2.34 ± 0.66 mN, p < 0.0001; 17.74 ± 2.45 mN/mm vs. 6.80 ± 1.32 mN/mm, p < 0.0001), and increased displacement at 1.96 mN (0.14 ± 0.02 mm vs. 0.29 ± 0.05 mm, p < 0.0001) along the injury zone. Implant‐treated VFs exhibited larger amplitude ratios and improved tissue architecture than untreated scars. No differences in quantitative measures were observed between implant‐treated and injection‐treated groups.

Conclusion

A light‐activatable dexamethasone implant improved VF biomechanics, vibratory behavior, and histological outcomes in a rabbit injury model comparable to a single steroid injection. This novel approach shows promise for delivering controlled, repeatable therapy to VF scars.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexamethasoneVocal CordsCicatrixGlucocorticoidsAnimalsRabbitsDrug ImplantsDisease Models, AnimalWound HealingInjections, Intralesional

Stichwörter der Autor:innen

controlled‐releasedrug deliverytherapeutic implantvocal fold scarring

Substanzen

DexamethasoneDrug ImplantsGlucocorticoids

Autor:innen und Institutionen

  • Medical Scientist Training Program, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
  • Department of Biomedical Engineering, College of Engineering and Applied Science, University of Cincinnati, Cincinnati, Ohio, USA.
  • Department of Otolaryngology-Head and Neck Surgery, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
  • Department of Chemical and Environmental Engineering, College of Engineering and Applied Science, University of Cincinnati, Cincinnati, Ohio, USA.

ORCID-Profile: Denzel Ryan D Cruz, Nour Awad, Avery Zheng, Alexander Karabachev, Charles Farbos de Luzan, Yoonjee C Park, Gregory R Dion

Förderung

  • NCATS NIH HHS
  • NIDCD NIH HHS
  • National Center for Advancing Translational Sciences
  • National Institutes of Health

Zitieren

APA

Cruz, D. R. D., Awad, N., Zheng, A., Karabachev, A., Farbos de Luzan, C., Park, Y. C., & Dion, G. R. (2026). Vocal Fold Scar Treatment via Controlled Dexamethasone Delivery With a Light‐Activatable Implant. The Laryngoscope. https://doi.org/10.1002/lary.70149

Vancouver

Cruz DRD, Awad N, Zheng A, Karabachev A, Farbos de Luzan C, Park YC, et al. Vocal Fold Scar Treatment via Controlled Dexamethasone Delivery With a Light‐Activatable Implant. The Laryngoscope. 2026. doi:10.1002/lary.70149

BibTeX
@article{Cruz2026,
  author = {Cruz, Denzel Ryan D and Awad, Nour and Zheng, Avery and Karabachev, Alexander and Farbos de Luzan, Charles and Park, Yoonjee C and Dion, Gregory R},
  title = {Vocal Fold Scar Treatment via Controlled Dexamethasone Delivery With a Light‐Activatable Implant},
  journal = {The Laryngoscope},
  year = {2026},
  doi = {10.1002/lary.70149}
}
Kostenlos starten →